<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ecam.oxfordjournals.org">
<title>Evidence-based Complementary and Alternative Medicine - Advance Access</title>
<link>http://ecam.oxfordjournals.org</link>
<description>Evidence-based Complementary and Alternative Medicine - RSS feed of articles</description>
<prism:eIssn>1741-4288</prism:eIssn>
<prism:publicationName>Evidence-based Complementary and Alternative Medicine</prism:publicationName>
<prism:issn>1741-427X</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen015v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen034v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen014v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen013v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen012v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen005v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem182v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nen002v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem174v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem179v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem175v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem139v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem150v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem149v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem123v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem164v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem129v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem124v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem168v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem122v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem081v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem074v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem165v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem153v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem169v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem145v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem083v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem118v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem084v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem120v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem099v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem166v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem161v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem157v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem146v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem143v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem136v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem163v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem160v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem151v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem126v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem080v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem062v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem156v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem144v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem142v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem141v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem127v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem125v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem102v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem089v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem158v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem152v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem148v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem147v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem071v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem070v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem137v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem138v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem132v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem103v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem130v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem097v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem131v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem128v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem121v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem119v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem101v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem098v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem082v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem104v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem100v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem086v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem085v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem091v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem090v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem048v2?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem079v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem078v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem076v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem088v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem077v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem064v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem059v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem057v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem073v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem068v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem063v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem052v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem051v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem050v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem067v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem066v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem065v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem060v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem049v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem061v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem058v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem056v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem055v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem054v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem035v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem047v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem045v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem044v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem042v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem036v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem034v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem032v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem031v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem029v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem030v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem028v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem027v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem026v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem025v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem016v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem014v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem019v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem018v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem017v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem010v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem015v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem008v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nem020v1?rss=1" />
  <rdf:li rdf:resource="http://ecam.oxfordjournals.org/cgi/content/short/nel096v1?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1">
<title><![CDATA[Macroscopic Quantum Coherence in Patient-Practitioner-Remedy Entanglement: The Quantized Fluctuation Field Perspective]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen032v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Hankey, A.]]></dc:creator>
<dc:date>2008-05-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen032</dc:identifier>
<dc:title><![CDATA[Macroscopic Quantum Coherence in Patient-Practitioner-Remedy Entanglement: The Quantized Fluctuation Field Perspective]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen015v1?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen015v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-05-14</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen015</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen034v1?rss=1">
<title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen034v1?rss=1</link>
<description><![CDATA[
<p>High-tech acupuncture research has been performed for 10 years at the Research Unit of Biomedical Engineering in Anesthesia and Intensive Care Medicine at the Medical University of Graz. This article as a part of a series comprises animal experiments in the field of needle and laser acupuncture. The investigations presented in this article were performed in pigs, dogs and sheep. In all studies sedative stimulation effects of the acupoint Yintang are described using different measurement parameters (EEG-bispectral index, EEG spectral edge frequency and metabolic parameters).</p>
]]></description>
<dc:creator><![CDATA[Litscher, G.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen034</dc:identifier>
<dc:title><![CDATA[Ten Years Evidence-based High-Tech Acupuncture Part 3: A Short Review of Animal Experiments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1">
<title><![CDATA[The Role of Dual-trained Conventional/Complementary Physicians as Mediators of Integration in Primary Care]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen033v1?rss=1</link>
<description><![CDATA[
<p>A growing number of physicians study complementary and alternative medicine (CAM). Limited data are available on perspectives of physicians with dual training in conventional medicine and CAM, on issues of communication and collaboration with CAM practitioners (CAMPs). Questionnaires were administered to primary care physicians employed in the largest health maintenance organization (HMO) in Israel and to MD and non-MD CAM practitioners employed by a CAM-related agency of the same HMO. Data for statistical analysis were available from 333 primary care physicians (PCPs) and 241 CAM practitioners. Thirty-one of the 241 CAMPs were dual-trained physicians employed in a CAM-related agency as practitioners and/or triage-consultants. Dual trained physicians and CAMPs shared similar attitudes and supported, more so than PCPs, collaborative physician&ndash;CAM practitioner teamwork in clinical practice, medical education and research. Nevertheless, dual trained physicians supported a physician-dominant teamwork model (similar to the PCPs&rsquo; approach) in contrast to non-MD CAM practitioners who mainly supported a co-directed teamwork model. Compared to PCPs and non-MD CAM practitioners, dual trained physicians supported significantly more a medical/referral letter as the preferred means of doctor&ndash;CAM practitioner communication. Dual trained physicians have a unique outlook toward CAM integration and physician&ndash;practitioner collaboration, compared to non-MD CAM practitioners and PCPs. More studies are warranted to explore the role of dual trained physicians as mediators of integration.</p>
]]></description>
<dc:creator><![CDATA[Ben-Arye, E.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen033</dc:identifier>
<dc:title><![CDATA[The Role of Dual-trained Conventional/Complementary Physicians as Mediators of Integration in Primary Care]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1">
<title><![CDATA[Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen031v1?rss=1</link>
<description><![CDATA[
<p>To explore pregnant women's use, attitudes, knowledge and beliefs of complementary and alternative drugs (CADs) defined as products manufactured from herbs or with a natural origin. A preliminary survey was conducted among 172 pregnant women in their third trimester of pregnancy, consecutively recruited in two obstetrical settings; 15 women were randomly selected to compute a <I>test-to-retest</I> analysis. Response rate was 87.2%. <I>Test-to-retest</I> analysis showed a questionnaire's reproducibility exceeding a <I>K</I>-value of 0.7 for all items. Mean age was 32.4 &plusmn; 0.4 years; most women were nulliparae (62.7%). The majority of subjects (68%) declared to have used one or more CADs during their lifetime; 48% of pregnant women reported taking at least one CAD previously and during the current pregnancy. Women's habitual use of CADs meant they were at higher risk of taking CADs also during pregnancy (adjusted odds ratio = 10.8; 95% confidence interval: 4.7&ndash;25.0). Moreover, 59.1% of the subjects were unable to correctly identify the type of CADs they were using. The majority of women resorted to gynecologists as the primary information source for CADs during pregnancy, while they mainly referred to herbalists when not pregnant. Habitual use of CADs seems to be a strong predictor for their ingestion also during pregnancy; in addition most subjects were unable to correctly identify the products they were taking. In the light of the scanty data concerning the safety of CADs during pregnancy, these preliminary results confirm the need to investigate thoroughly the situation of pregnant women and CADs consumption.</p>
]]></description>
<dc:creator><![CDATA[Lapi, F., Vannacci, A., Moschini, M., Cipollini, F., Morsuillo, M., Gallo, E., Banchelli, G., Cecchi, E., Pirro, M. D., Giovannini, M. G., Cariglia, M. T., Gori, L., Firenzuoli, F., Mugelli, A.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen031</dc:identifier>
<dc:title><![CDATA[Use, Attitudes and Knowledge of Complementary and Alternative Drugs (CADs) Among Pregnant Women: a Preliminary Survey in Tuscany]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1">
<title><![CDATA[Physiological Adjustments to Stress Measures Following Massage Therapy: A Review of the Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen029v1?rss=1</link>
<description><![CDATA[
<p>Use of massage therapy by the general public has increased substantially in recent years. In light of the popularity of massage therapy for stress reduction, a comprehensive review of the peer-reviewed literature is important to summarize the effectiveness of this modality on stress-reactive physiological measures. On-line databases were searched for articles relevant to both massage therapy and stress. Articles were included in this review if (i) the massage therapy account consisted of manipulation of soft tissues and was conducted by a trained therapist, and (ii) a dependent measure to evaluate physiological stress was reported. Hormonal and physical parameters are reviewed. A total of 25 studies met all inclusion criteria. A majority of studies employed a 20&ndash;30 min massage administered twice-weekly over 5 weeks with evaluations conducted pre-post an individual session (single treatment) or following a series of sessions (multiple treatments). Single treatment reductions in salivary cortisol and heart rate were consistently noted. A sustained reduction for these measures was not supported in the literature, although the single-treatment effect was repeatable within a study. To date, the research data is insufficient to make definitive statements regarding the multiple treatment effect of massage therapy on urinary cortisol or catecholamines, but some evidence for a positive effect on diastolic blood pressure has been documented. While significant improvement has been demonstrated following massage therapy, the general research body on this topic lacks the necessary scientific rigor to provide a definitive understanding of the effect massage therapy has on many physiological variables associated with stress.</p>
]]></description>
<dc:creator><![CDATA[Moraska, A., Pollini, R. A., Boulanger, K., Brooks, M. Z., Teitlebaum, L.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen029</dc:identifier>
<dc:title><![CDATA[Physiological Adjustments to Stress Measures Following Massage Therapy: A Review of the Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1">
<title><![CDATA[Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen027v1?rss=1</link>
<description><![CDATA[
<p>The effect of practicing yoga for the management of type II Diabetes was assessed in this systematic review through searching related electronic databases and the grey literature to the end of May 2007 using Ovid. All randomized controlled clinical trials (RCTs) comparing yoga practice with other type of intervention or with regular practice or both, were included regardless of language or type of publication. Each study was assessed for quality by two independent reviewers. Mean difference was used for summarizing the effect of each study outcomes with 95% confidence intervals. Pooling of the studies did not take place due to the wide clinical variation between the studies. Publication bias was assessed by statistical methods. Five trials with 363 participants met the inclusion criteria with medium to high risk of bias and different intervention characteristics. The studies&rsquo; results show improvement in outcomes among patients with diabetes type II. These improvements were mainly among short term or immediate diabetes outcomes and not all were statistically significant. The results were inconclusive and not significant for the long-term outcomes. No adverse effects were reported in any of the included studies. Short-term benefits for patients with diabetes may be achieved from practicing yoga. Further research is needed in this area. Factors like quality of the trials and other methodological issues should be improved by large randomized control trials with allocation concealment to assess the effectiveness of yoga on diabetes type II. A definitive recommendation for physicians to encourage their patients to practice yoga cannot be reached at present.</p>
]]></description>
<dc:creator><![CDATA[Aljasir, B., Bryson, M., Al-shehri, B.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen027</dc:identifier>
<dc:title><![CDATA[Yoga Practice for the Management of Type II Diabetes Mellitus in Adults: A systematic review]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1">
<title><![CDATA[Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen026v1?rss=1</link>
<description><![CDATA[
<p>Traditional Japanese medicine uses the leaves of Kumaizasa bamboo extracted in hot water at 100&deg;C. For this study, we developed a new, &lsquo;vigorous&rsquo; extraction method involving steps at 100, 121 and 196&deg;C. This procedure not only yielded greater amounts of extract but also with significant increase in immunostimulating activity, which induces activation of human natural killer (NK) cells, macrophages and potent induction of IL-2, IL-12 and IFN- in tumor bearing mice. The efficacy of the extract to facilitate phagocytosis and nitric oxide production by mouse peritoneal macrophages was determined and compared with that of 1,3-&beta;-glucan. Anti-tumor activity was evaluated <I>in vivo</I> in several mouse tumor models (S-180, C38 and Meth-A). Oral administration of the extracts was carried out when tumor reached size of approximately 6 mm at concentrations of 0.05% or higher. The extracts significantly suppressed tumor growth in S-180 and C38 tumor models. Overall survival was significantly prolonged in the treatment group than that of control. Activation of macrophages and NK cells by the extracts suggests that the anti-tumor efficacy of the extract is mediated by immunopotentiation. The extracts resolved into three major fractions (F-I, F-II and F-III) in Sephadex gel chromatography. Fraction F-I consists of 1,3-&beta;-glucan and stimulated both macrophages and NK cells suggesting that it may be the primary immunopotentiating factor in suppressing cancer. Fraction F-III has potent free radical scavenging effects and may play an important role in cancer prevention. These results warrant further translation and clinical investigations.</p>
]]></description>
<dc:creator><![CDATA[Seki, T., Kida, K., Maeda, H.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen026</dc:identifier>
<dc:title><![CDATA[Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen014v1?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part II]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen014v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-05-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen014</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part II]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1">
<title><![CDATA[In vitro anti-plasmodial activity of Trigonella foenum-graecum L.]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen030v1?rss=1</link>
<description><![CDATA[
<p>Developing countries, where malaria is one of the most prevalent diseases, still rely on traditional medicine as a source for the treatment of this disease. For the present study, <I>Trigonella foenum-graecum</I> L. (fenugreek) were collected from Coimbatore, Tamilnadu, India. The test plant has been used in India by traditional healers for the treatment of fever as well as other diseases. The active principle was extracted out in different solvent systems to assess the anti-plasmodial potential, with an aim that they can further be utilized to formulate drugs. <I>In vitro</I> anti-plasmodial assay of the extracted fractions of fenugreek leaves was carried out using laboratory adapted chloroquine sensitive and resistant <I>Plasmodium falciparum</I> isolates. Schizont maturation inhibition assay was adopted to analyze the potential of the extracts. Ethanol extract (50%) seemed to possess profound anti-plasmodial activity with IC<SUB>50</SUB> value of 8.75 &plusmn; 0.35 &micro;g ml<sup>&ndash;1</sup> and 10.25 &plusmn; 0.35 &micro;g ml<sup>&ndash;1</sup> against chloroquine sensitive and resistant <I>P. falciparum</I> isolates, respectively. Among the investigated six fractions of the plant extracts, two were found to have significant anti-plasmodial activity with IC<SUB>50</SUB> values &lt;10 &micro;g ml<sup>&ndash;1</sup>, namely ethanol and butanol extracts. Two extracts chloroform and ethyl acetate showed moderate activity with IC<SUB>50</SUB> values ranging from 10 to 20 &micro;g ml<sup>&ndash;1</sup>, and the other two extracts, hexane and water appeared to be inactive with IC<SUB>50</SUB> values &gt;85 &micro;g ml<sup>&ndash;1</sup>. In addition, preliminary phytochemical screening of the various extracts indicated the presence of alkaloids, saponin, tannin like phenolic compounds, flavonoids and steroids.</p>
]]></description>
<dc:creator><![CDATA[Palaniswamy, M., Pradeep, B. V., Sathya, R., Angayarkanni, J.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen030</dc:identifier>
<dc:title><![CDATA[In vitro anti-plasmodial activity of Trigonella foenum-graecum L.]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1">
<title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen028v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Logue, E. H.]]></dc:creator>
<dc:date>2008-05-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen028</dc:identifier>
<dc:title><![CDATA['The Science of CAIM: What's Next for Complementary, Alternative and Integrative Medical Research?']]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-05-02</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1">
<title><![CDATA[Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen025v1?rss=1</link>
<description><![CDATA[
<p>Mistletoe preparations such as Iscador are in common use as complementary/anthroposophic medications for many cancer indications, particularly for solid cancers. The efficacy is still discussed controversially. This paper presents an individual patient data meta-analysis of all published prospective matched-pair studies with breast cancer patients concerned with long-term application of a complementary/anthroposophic therapy with the mistletoe preparation Iscador. Six sets of data were available for individual patient meta-analysis of breast cancer patients, matched according to prognostic factors into pairs with and without mistletoe (Iscador) therapy. The main outcome measures were overall survival and psychosomatic self-regulation. Overall survival was almost significant in favor of the Iscador group in the combined data set of the randomized studies: estimate of the hazard ratio with 95% confidence interval 0.59 (0.34, 1.02). Overall survival was highly significant in the combined data set of the non-randomized studies: 0.43 (0.34, 0.56). In the combined analysis of the randomized studies, improvement of psychosomatic self-regulation, as a measure of autonomous coping with the disease, was highly significant in favor of the Iscador group: estimate of the median difference 0.45 (0.15, 0.80), <I>P</I> = 0.0051. The analyzed studies show that therapy with Iscador might prolong overall survival and improve psychosomatic self-regulation of breast cancer patients.</p>
]]></description>
<dc:creator><![CDATA[Ziegler, R., Grossarth-Maticek, R.]]></dc:creator>
<dc:date>2008-04-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen025</dc:identifier>
<dc:title><![CDATA[Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-04-11</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1">
<title><![CDATA[The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen024v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Feingold, E.]]></dc:creator>
<dc:date>2008-04-09</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen024</dc:identifier>
<dc:title><![CDATA[The Homeopathic Revolution: Why Famous People and Cultural Heroes Choose Homeopathy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-04-09</prism:publicationDate>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen013v1?rss=1">
<title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part I]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen013v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Mashelkar, R. A.]]></dc:creator>
<dc:date>2008-04-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen013</dc:identifier>
<dc:title><![CDATA[Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part I]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-04-03</prism:publicationDate>
<prism:section>Lecture Series</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1">
<title><![CDATA[Soybeans Ameliolate Diabetic Nephropathy in Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen021v1?rss=1</link>
<description><![CDATA[
<p>Diabetic nephropathy is one of the most frequent and serious complications of diabetes mellitus. Soybeans have been shown to reduce urinary albumin excretion and total cholesterol in non-diabetic patients with nephrotic syndrome. However, reports focusing specifically on diabetic nephropathy are scarce and the available results are inconsistent. It was reported that soybean consumption reduced urinary protein excretion in type 1 diabetic patients with diabetic nephropathy, whereas it was found to elicit an increase in urinary protein excretion when soybeans were consumed by type 2 diabetic patients. This study aims to investigate the effects of soybean in diabetic nephropathy, particularly the effects of consuming soybeans on the histopathology of diabetic nephropathy, using aquaporin (AQP) and osteopontin (OPN) expression as diagnostic markers. Male Sprague-Dawley rats were assigned to one of three groups: control, diabetic with red chow diet and diabetic with soybean diet. For histological examination, the expression of OPN and AQP, renal function and hemoglobin A1c were evaluated at the end of the study. Improvements in glomerular and tubulointerstitial lesions were demonstrated in the diabetic rat group given a soybean diet. OPN and AQP expression were suppressed in the kidney specimens of diabetic rats with the soybean diet. In conclusion, soybeans may prevent the weight loss and morphological disruption of the kidney associated with diabetes mellitus. Soybeans also may improve glycemic control. It seems likely that long-term control of blood glucose levels using a soybean diet could prevent the progression of diabetes mellitus, and therefore, nephropathy could be prevented.</p>
]]></description>
<dc:creator><![CDATA[Choi, Y. E., Ahn, S. K., Lee, W. T., Lee, J. E., Park, S. H., Yoon, B. B., Park, K. A.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen021</dc:identifier>
<dc:title><![CDATA[Soybeans Ameliolate Diabetic Nephropathy in Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1">
<title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen020v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Speight, N., Hynote, E. D.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen020</dc:identifier>
<dc:title><![CDATA[Summary of the American College for Advancement in Medicine November 2007 Conference on Integrative Medicine: Advancing Science and Clinical Practice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1">
<title><![CDATA[MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen019v1?rss=1</link>
<description><![CDATA[
<p>We examined the <I>in vitro</I> anti-human immunodeficiency virus (HIV) activity of MRN-100, an iron-based compound derived from bivalent and tervalent ferrates. MRN-100 action against HIV-1 (SF strain) was tested in primary cultures of peripheral blood mononuclear cells (MNC) by analyzing p24 antigen production and percent survival of MNC infected with HIV. MRN-100 at a concentration of 10% (v/v) inhibited HIV-1 replication in 11 out of 14 samples (79%). The percentage of suppression of p24 antigen was &ndash;12.3 to 100% at 10 days post-treatment. MRN-100 also exhibited a significant protective effect in the survival of HIV-1-infected MNC. MNC survival post-treatment was dose dependent, 70.4% &plusmn; 8.4, 83.6% &plusmn; 10.7 and 90% &plusmn; 11.4, at concentrations 2.5, 5 and 10% (v/v), respectively, as compared with 53% &plusmn; 4 for HIV-1-infected MNC without treatment. The effect was detected as early as 4 days and continued up to 11 days. Treatment with MRN-100 caused no significant change in proliferative response of MNC alone or cocultured with different mitogens: PHA and Con-A (activators of T cell function) and PWM (activator of CD4<sup>+</sup> T cell-dependent B cells). We concluded that MRN-100 possesses anti-HIV activity <I>in vitro</I> and without an increase in lymphocyte proliferation, MRN-100 may be a useful agent for treating patients with acquired immunodeficiency syndrome.</p>
]]></description>
<dc:creator><![CDATA[Ghoneum, M., Shaheen, M.]]></dc:creator>
<dc:date>2008-03-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen019</dc:identifier>
<dc:title><![CDATA[MRN-100, an Iron-based Compound, Possesses Anti-HIV Activity In Vitro]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1">
<title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen023v1?rss=1</link>
<description><![CDATA[
<p>Complementary and Alternative Medicines (CAM) are used by an extensive number of patients in the UK and elsewhere. In order to understand this pattern of behavior, it is helpful to examine the characteristics of people who use CAM. This narrative review collates and evaluates the evidence concerning the demographic characteristics and health status factors associated with CAM use in community-based non-clinical populations. A systematic literature search of computerized databases was conducted, and published research papers which present evidence concerning associations between CAM use and demographic and health characteristics are discussed and evaluated. The evidence suggests that people who use CAM tend to be female, of middle age and have more education. In terms of their health, CAM users tend to have more than one medical condition, but might not be more likely than non-users to have specific conditions such as cancer or to rate their own general health as poor. The multivariate studies that have been conducted suggest that both demographic and health characteristics contribute independently to CAM use. In conclusion, demographic characteristics and factors related to an individual's health status are associated with CAM use. Future research is needed to address methodological limitations in existing studies.</p>
]]></description>
<dc:creator><![CDATA[Bishop, F. L., Lewith, G. T.]]></dc:creator>
<dc:date>2008-03-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen023</dc:identifier>
<dc:title><![CDATA[Who Uses CAM? A Narrative Review of Demographic Characteristics and Health Factors Associated with CAM Use]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-13</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1">
<title><![CDATA[Prognostic Ability of Practitioners of Traditional Arabic Medicine: Comparison with Western Methods Through a Relative Patient Progress Scale]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen022v1?rss=1</link>
<description><![CDATA[
<p>The ancient Greek medical theory based on balance or imbalance of humors disappeared in the western world, but does survive elsewhere. Is this survival related to a certain degree of health care efficiency? We explored this hypothesis through a study of classical Greco-Arab medicine in Mauritania. Modern general practitioners evaluated the safety and effectiveness of classical Arabic medicine in a Mauritanian traditional clinic, with a prognosis/follow-up method allowing the following comparisons: (i) actual patient progress (clinical outcome) compared with what the traditional &lsquo;tabib&rsquo; had anticipated (= prognostic ability) and (ii) patient progress compared with what could be hoped for <I>if</I> the patient were treated by a modern physician in the same neighborhood. The practice appeared fairly safe and, on average, clinical outcome was similar to what could be expected with modern medicine. In some cases, patient progress was better than expected. The ability to correctly predict an individual's clinical outcome did not seem to be better along modern or Greco-Arab theories. Weekly joint meetings (modern and traditional practitioners) were spontaneously organized with a modern health centre in the neighborhood. Practitioners of a different medical system can predict patient progress. For the patient, avoiding false expectations with health care and ensuring appropriate referral may be the most important. Prognosis and outcome studies such as the one presented here may help to develop institutions where patients find support in making their choices, not only among several treatment options, but also among several medical systems.</p>
]]></description>
<dc:creator><![CDATA[Graz, B.]]></dc:creator>
<dc:date>2008-03-13</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen022</dc:identifier>
<dc:title><![CDATA[Prognostic Ability of Practitioners of Traditional Arabic Medicine: Comparison with Western Methods Through a Relative Patient Progress Scale]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-03-13</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1">
<title><![CDATA[Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen011v1?rss=1</link>
<description><![CDATA[
<p>High morbidity and mortality associated with oral squamous cell carcinoma (OSCC) are largely attributable to late stage diagnosis. Despite significant advances in therapeutic strategies, the five-year survival rate for oral cancer remains at about 50%. A chemopreventive approach may be an effective alternative or adjunct to current therapies. Previous studies have shown anti-tumor effects of isoflavones in several cancers, including oral cancer. However, their mechanisms of action are still unclear. We hypothesized that isoflavones inhibit multiple signaling pathways implicated in oral carcinogenesis. To address our hypothesis, we investigated the effects of three isoflavone derivatives, genistein, biochanin A and daidzein, on SCC15 and SCC25 squamous cell carcinoma cell lines. In cell proliferation experiments, we found that genistein and biochanin A inhibited SCC15 and SCC25 cell growth with an IC50 of 50 &micro;M. We also investigated the effect of isoflavones on ERK and Akt pathways. Our results, from western blot analysis, suggest that both genistein and biochanin A induced decreases in phosphorylation of ERK and Akt at treatment concentrations of 20, 50 and 100 &micro;M. Taken together, our results clearly demonstrate a differential regulation of signaling pathways by various isoflavones in OSCC cell lines. Thus, tumor progression models can be utilized to study the preventive and therapeutic roles of isoflavones in oral cancer cell lines.</p>
]]></description>
<dc:creator><![CDATA[Johnson, T. L., Lai, M. B., Lai, J. C. K., Bhushan, A.]]></dc:creator>
<dc:date>2008-02-29</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen011</dc:identifier>
<dc:title><![CDATA[Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-29</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1">
<title><![CDATA[Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen018v1?rss=1</link>
<description><![CDATA[
<p><I>Satureja khuzestanica</I> is an endemic plant of Iran that is widely distributed in the Southern part of the country. It has antioxidant properties and thus it seems to be useful in diseases related to oxidative stress such as diabetes and hyperlipidemia. The present study investigates the effect of <I>S. khuzestanica</I> supplement in metabolic parameters of hyperlipidemic patients with type 2 diabetes mellitus. Twenty-one hyperlipidemic patients with type 2 diabetes mellitus were randomized in a double blind, placebo controlled clinical trial to receive either <I>S. khuzestanica</I> (tablets contain 250 mg dried leaves) or placebo once a day for 60 days. Blood samples were obtained at baseline and at the end of the study. Samples were analyzed for levels of glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, thiobarbituric acid reactive substances (TBARS) as marker of lipid peroxidation and ferric reducing ability (total antioxidant power, TAP). Treatment of patients by <I>S. khuzestanica</I> for 60 days induced significant decrease in total cholesterol (<I>P</I> = 0.008) and LDL-cholesterol (<I>P</I> = 0.03) while increased HDL-cholesterol (<I>P</I> = 0.02) and TAP (<I>P</I> = 0.007) in comparison with the baseline values. <I>S. khuzestanica</I> did not alter blood glucose, triglyceride, creatinin and TBARS levels. In comparison with baseline values, no significant change was observed in blood glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, creatinine, TBARS and TAP in placebo-treated group. Usage of <I>S. khuzestanica</I> as a supplement to drug regimen of diabetic type 2 patients with hyperlipidemia is recommended.</p>
]]></description>
<dc:creator><![CDATA[Vosough-Ghanbari, S., Rahimi, R., Kharabaf, S., Zeinali, S., Mohammadirad, A., Amini, S., Yasa, N., Salehnia, A., Toliat, T., Nikfar, S., Larijani, B., Abdollahi, M.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen018</dc:identifier>
<dc:title><![CDATA[Effects of Satureja khuzestanica on Serum Glucose, Lipids and Markers of Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1">
<title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen017v1?rss=1</link>
<description><![CDATA[
<p>More and more patients have been diagnosed as having chronic fatigue syndrome (CFS) in recent years. Western drug use for this syndrome is often associated with many side-effects and little clinical benefit. As an alternative medicine, traditional Chinese medicine (TCM) has provided some evidences based upon ancient texts and recent studies, not only to offer clinical benefit but also offer insights into their mechanisms of action. It has perceived advantages such as being natural, effective and safe to ameliorate symptoms of CFS such as fatigue, disordered sleep, cognitive handicaps and other complex complaints, although there are some limitations regarding the diagnostic standards and methodology in related clinical or experimental studies. Modern mechanisms of TCM on CFS mainly focus on adjusting immune dysfunction, regulating abnormal activity in the hypothalamic-pituitary-adrenal (HPA) axis and serving as an antioxidant. It is vitally important for the further development to establish standards for &lsquo;zheng&rsquo; of CFS, i.e. the different types of CFS pathogenesis in TCM, to perform randomized and controlled trials of TCM on CFS and to make full use of the latest biological, biochemical, molecular and immunological approaches in the experimental design.</p>
]]></description>
<dc:creator><![CDATA[Chen, R., Moriya, J., Yamakawa, J.-i., Takahashi, T., Kanda, T.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen017</dc:identifier>
<dc:title><![CDATA[Traditional Chinese Medicine for Chronic Fatigue Syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1">
<title><![CDATA[Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen007v1?rss=1</link>
<description><![CDATA[
<p>Kampo (traditional Japanese herbal) medicines are taken orally due to which the gastric mucosal immune system may act as one of the major targets for the expression of pharmacological activity. The inner surface of the intestinal tract possesses a large area of mucosal membranes, and the intestinal epithelial cells sit at the interface between a lumen and a lymphocyte-rich lamina propria. The cross talk that occurs between these compartments serves to maintain intestinal homeostasis, and the cytokine network plays an important role in the cross talk. In this study, the effect of Hochuekkito (HET), one of Kampo medicines, on cytokine secretion of intestinal epithelial cells was investigated. When murine normal colonic epithelial cell-line MCE301 cells were stimulated with HET, the contents of granulocyte colony-stimulating factor (G-CSF) in the conditioned medium were significantly increased in dose- and time-dependent manners. The enhanced G-CSF gene transcription in MCE301 cells by the stimulation of HET was observed by RT-PCR. The enhanced G-CSF secretion by HET was also observed in C3H/HeJ mice-derived primary cultured colonic epithelial cells. When the HET was fractionated, only the polysaccharide fraction (F-5) enhanced the G-CSF secretion of MCE301 cells, and the activity of F-5 lost after the treatment of periodate that can degrade the carbohydrate moiety. These results suggest that HET enhances secretion of G-CSF from colonic epithelial cells and the polysaccharide is one of the active ingredients of HET. The enhanced G-CSF secretion by HET may partly contribute to the clinically observed various pharmacological activities of HET including immunomodulating activity.</p>
]]></description>
<dc:creator><![CDATA[Matsumoto, T., Moriya, M., Kiyohara, H., Tabuchi, Y., Yamada, H.]]></dc:creator>
<dc:date>2008-02-27</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen007</dc:identifier>
<dc:title><![CDATA[Hochuekkito, a Kampo (Traditional Japanese Herbal) Medicine, and its Polysaccharide Portion Stimulate G-CSF Secretion from Intestinal Epithelial Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-27</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen012v1?rss=1">
<title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen012v1?rss=1</link>
<description><![CDATA[
<p>Two consecutive conferences on &lsquo;Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine&rsquo; were held in Xinjiang Medical University on July 3 and Kanazawa Medical University on October 6, 2007. The Vice president Halmurat Upur presided over the meeting and gave congratulatory address on holding of the conference. In order to understand mutually and discuss the possibility of the Uighur Medicine as CAM and the situation of medicine in the global sense, specialist scholars of Traditional Uighur Medicine and postgraduates attended this conference. In the meeting of the CAM, the achievements on the research of Traditional Uighur Medicine were exchanged and warmly discussed. Presentations were made in the consecutive conference.</p>
]]></description>
<dc:creator><![CDATA[Yusup, A., Yamaguchi, N.]]></dc:creator>
<dc:date>2008-02-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen012</dc:identifier>
<dc:title><![CDATA[Aspects of Sino-Japan Complementary and Alternative Medicine and Development on the Traditional Uighur Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-26</prism:publicationDate>
<prism:section>Meeting Report</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1">
<title><![CDATA[Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen010v1?rss=1</link>
<description><![CDATA[
<p>Goal of this study was to evaluate effects of Mao-to on development of myocarditis induced by encephalomyocarditis (EMC) virus in mice. Mice were randomly divided into five groups. Group N included uninfected controls (<I>n</I> = 18), while group A, B and C underwent intraperitoneal injection of EMC virus. Group A was administered oral saline from day 0 to day 4. Group B was administered oral Mao-to (500 mg<sup>&ndash;1</sup> kg<sup>&ndash;1</sup> day<sup>&ndash;1</sup>) from day 0 to day 4. Group C was administered Mao-to from day 2 to day 6. Group D was administered Mao-to from day 5 to day 10. Treated mice were followed for survival rates during 2 weeks after infection. Body weight (BW) and organ weights including heart (HW), lungs, thymus and spleen were examined on days 4, 6 and 14. Survival rate of group C (36.4%) was significantly improved compared with group A, B or D (0% of each, <I>P</I> &lt; 0.05). HW and HW/BW ratio in group C was significantly (<I>P</I> &lt; 0.05) lower than those in group A, B or D. Viral titers of hearts were significantly different among groups A, B and C. Cardiac expression in tumor necrosis factor- (TNF-) was significantly reduced in group C in comparison with group A, B or D on day 6 by immunohistochemical study. Administration of Mao-to starting on day 2 improves mortality resulting from viral myocarditis in mice with reduced expression of cardiac TNF-. These findings suggest that timing of Mao-to is crucial for preventing cardiac damage in mice with viral myocarditis.</p>
]]></description>
<dc:creator><![CDATA[Shijie, Z., Moriya, J., Yamakawa, J., Chen, R., Takahashi, T., Sumino, H., Nakahashi, T., Iwai, K., Morimoto, S., Yamaguchi, N., Kanda, T.]]></dc:creator>
<dc:date>2008-02-24</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen010</dc:identifier>
<dc:title><![CDATA[Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-24</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1">
<title><![CDATA[Black Cohosh Hepatic Safety: Follow-up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen009v1?rss=1</link>
<description><![CDATA[
<p>European Medicines Agency (EMEA) and the Committee on Herbal Medicinal Products (HMPC) on July 2006 have released an alert to get European sanitary authorities aware of 42 cases of suspected hepatotoxic reactions in patients consuming <I>Cimicifuga racemosa rhizome</I>. In the public statement EMEA itself considered reliable as hepatotoxic reactions only four cases, on the base of RUCAM score: two were considered possible and two probable. Lacking in almost all of them a precise description of cases, especially a botanical&ndash;chemical analysis of the suspected substance, we think there is no real proof of supposed <I>C. racemosa rhizome</I> hepatotoxicity. In our department we administer from about 10 years <I>C. racemosa</I> as special herbal dry extract as single substance or mixed with other medicinal plants at the dose of 500&ndash;1000 mg daily, for treatment of menopause related disorders without any reported adverse effect. After EMEA's official signal we have contacted all our patients using a <I>C. racemosa rhizome</I> herbal extract continuously from more than 12 months to verify possible hepatotoxic effects. We followed-up 107 women, and asked them by telephone (33/107) and/or after anamnesis and clinical examination (74/107) to undergo a blood sample examination. In all the patients there was no sign of hepatic disease, or worsening of already altered but stable parameters. We think on the base of these data and current literature <I>C. racemosa rhizome</I> extract should not be considered a potential hepatotoxic substance.</p>
]]></description>
<dc:creator><![CDATA[Firenzuoli, F., Gori, L., di Sarsina, P. R.]]></dc:creator>
<dc:date>2008-02-20</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen009</dc:identifier>
<dc:title><![CDATA[Black Cohosh Hepatic Safety: Follow-up of 107 Patients Consuming a Special Cimicifuga racemosa rhizome Herbal Extract and Review of Literature]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-20</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1">
<title><![CDATA[Lipid Lowering Activity of Anthocephalus indicus Root in Hyperlipidemic Rats]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen001v1?rss=1</link>
<description><![CDATA[
<p>The lipid lowering activity of <I>Anthocephalus indicus</I> (family Rubiaceae; Hindi name Kadamba) root extract has been studied in triton WR-1339 induced hyperlipidemia in rats. In this model, feeding with root extract (500 mg kg<sup>&ndash;1</sup> b.w.) lowered plasma lipids and reactivated post-heparin lipolytic activity in hyperlipidemic rats. Furthermore, the root extract (50&ndash;500 &micro;M) inhibited the generation of superoxide anions and hydroxyl radicals, in both enzymic and non-enzymic systems, <I>in vitro</I>. The results of the present study demonstrated both lipid lowering and antioxidant activities in root extract of <I>A. indicus</I>, which could help prevention of hyperlipidemia and related diseases.</p>
]]></description>
<dc:creator><![CDATA[Kumar, V., Khan, M. M., Khanna, A. K., Singh, R., Singh, S., Chander, R., Mahdi, F., Mahdi, A. A., Saxena, J. K., Singh, R. K.]]></dc:creator>
<dc:date>2008-02-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen001</dc:identifier>
<dc:title><![CDATA[Lipid Lowering Activity of Anthocephalus indicus Root in Hyperlipidemic Rats]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1">
<title><![CDATA[History and Progress of Japanese Acupuncture]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem155v1?rss=1</link>
<description><![CDATA[
<p>After Chiso brought acupuncture to Japan from Wu (China) in the sixth century, it has progressed in unique ways within the various historical milieus of the past 1500 years. Ishitsu-rei, the first medical law of Japan established in 701, explains the medical system of acupuncture in detail showing that acupuncture was being administered under the authorization of the national government. For the next 1200 years, acupuncture continued to be an important facet of public health in Japan. From the Azuchimomoyama through the Edo period, the knowledge exchange with China became active and people who studied in China developed new styles and techniques of acupuncture treatment and organized their own private schools or <I>ryu-ha</I> in Japan. In 1635, when the Edo government decided to close the country, Japan cut-off exchange with foreign countries for over 200 years. The national isolation caused some development that was unique to Japan. During that time, acupuncture filtered into people's everyday lives. Moxibustion, in particular, became popular as a treatment that ordinary people could practice by themselves. Also in this period of isolation, Western medicine was imported from Holland, the only country allowed to maintain trade with Japan. This novel modern medicine had a strong impact on Japanese medicine, which has its foundation of Chinese traditional medicine. At the same time, Japanese acupuncture was introduced into Europe via Holland. When Japan opened its borders in 1865 period, the new government was eager to accept Western culture to the extent of prohibiting the progress of Japanese acupuncture for a period of time. Even so, Japanese acupuncture has survived and flourished up to the present day due to the strong demand and the great efforts of the practitioners. Scientific studies are now in the process of establishing a firm evidence base for over a millennium of clinical use, respecting the classic ideas of the traditional treatment.</p>
]]></description>
<dc:creator><![CDATA[Kobayashi, A., Uefuji, M., Yasumo, W.]]></dc:creator>
<dc:date>2008-02-04</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem155</dc:identifier>
<dc:title><![CDATA[History and Progress of Japanese Acupuncture]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-04</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1">
<title><![CDATA[The Effect of Therapeutic Touch on Pain and Fatigue of Cancer Patients Undergoing Chemotherapy]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen006v1?rss=1</link>
<description><![CDATA[
<p>Despite major advances in pain management, cancer pain is managed poorly in 80% of the patients with cancer. Due to deleterious side effects of pharmacology therapy in these people, there is an urgent need for clinical trials of non-pharmacological interventions. To examine the effect of therapeutic touch (TT) on the pain and fatigue of the cancer patients undergoing chemotherapy, a randomized and three-groups experimental study&mdash;experimental (TT), placebo (placebo TT), and control (usual care)&mdash;was carried out. Ninety patients undergoing chemotherapy, exhibiting pain and fatigue of cancer, were randomized into one of the three groups in the Cancer Center of Imam Khomeini Hospital in Tehran, Iran. Pain and fatigue were measured and recorded by participants before and after the intervention for 5 days (once a day). The intervention consisted of 30 min TT given once a day for 5 days between 10:00 a.m. and 10:30 a.m. The Visual Analogue Scale (VAS) of pain and the Rhoten Fatigue Scale (RFS) were completed for 5 days before and after the intervention by the subjects. The TT (significant) was more effective in decreasing pain and fatigue of the cancer patients undergoing chemotherapy than the usual care group, while the placebo group indicated a decreasing trend in pain and fatigue scores compared with the usual care group.</p>
]]></description>
<dc:creator><![CDATA[Aghabati, N., Mohammadi, E., Pour Esmaiel, Z.]]></dc:creator>
<dc:date>2008-02-02</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen006</dc:identifier>
<dc:title><![CDATA[The Effect of Therapeutic Touch on Pain and Fatigue of Cancer Patients Undergoing Chemotherapy]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-02-02</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1">
<title><![CDATA[Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen003v1?rss=1</link>
<description><![CDATA[
<p><I>Hochu-ekki-to</I> is a traditional herbal (Kampo) medicine that has been shown to be effective for patients with <I>Kikyo</I> (delicate, easily fatigable, or hypersensitive) constitution. Previous case reports have suggested that this herbal drug was effective for a certain subgroup of patients with atopic dermatitis (AD). We aimed to evaluate the efficacy and safety of <I>Hochu-ekki-to</I> in the long-term management of <I>Kikyo</I> patients with AD. In this multicenter, double blind, randomized, placebo-controlled study, 91 <I>Kikyo</I> patients with AD were enrolled. <I>Kikyo</I> condition was evaluated by a questionnaire scoring system. All patients continued their ordinary treatments (topical steroids, topical tacrolimus, emollients or oral antihistamines) before and after their protocol entry. <I>Hochu-ekki-to</I> or placebo was orally administered twice daily for 24 weeks. The skin severity scores, total equivalent amount (TEA) of topical agents used for AD treatment, prominent efficacy (cases with skin severity score = 0 at the end of the study) rate and aggravated rate (more than 50% increase of TEA of topical agents from the beginning of the study) were monitored and evaluated. Seventy-seven out of 91 enrolled patients completed the 24-week treatment course (<I>Hochu-ekki-to</I>: <I>n</I> = 37, placebo: <I>n</I> = 40). The TEA of topical agents (steroids and/or tacrolimus) was significantly (<I>P</I> &lt; 0.05) lower in the <I>Hochu-ekki-to</I> group than in the placebo group, although the overall skin severity scores were not statistically different. The prominent efficacy rate was 19% (7 of 37) in the <I>Hochu-ekki-to</I> group and 5% (2 of 40) in the placebo group (<I>P</I> = 0.06). The aggravated rate was significantly (<I>P</I> &lt; 0.05) lower in the <I>Hochu-ekki-to</I> group (3%; 1 of 37) than in the placebo group (18%; 7 of 39). Only mild adverse events such as nausea and diarrhea were noted in both groups without statistical difference. This placebo-controlled study demonstrates that <I>Hochu-ekki-to</I> is a useful adjunct to conventional treatments for AD patients with <I>Kikyo</I> constitution. Use of <I>Hochu-ekki-to</I> significantly reduces the dose of topical steroids and/or tacrolimus used for AD treatment without aggravating AD.</p>
]]></description>
<dc:creator><![CDATA[Kobayashi, H., Ishii, M., Takeuchi, S., Tanaka, Y., Shintani, T., Yamatodani, A., Kusunoki, T., Furue, M.]]></dc:creator>
<dc:date>2008-01-31</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen003</dc:identifier>
<dc:title><![CDATA[Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-31</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1">
<title><![CDATA[Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem177v1?rss=1</link>
<description><![CDATA[
<p>Total phenolic contents, antioxidant activity and chemical composition of propolis samples from three localities of Minas Gerais state (southeast Brazil) were determined. Total phenolic contents were determined by the Folin&ndash;Ciocalteau method, antioxidant activity was evaluated by DPPH, using BHT as reference, and chemical composition was analyzed by GC/MS. Propolis from Itapecerica and Paula C&acirc;ndido municipalities were found to have high phenolic contents and pronounced antioxidant activity. From these extracts, 40 substances were identified, among them were simple phenylpropanoids, prenylated phenylpropanoids, sesqui- and diterpenoids. Quantitatively, the main constituent of both samples was allyl-3-prenylcinnamic acid. A sample from Virgin&oacute;polis municipality had no detectable phenolic substances and contained mainly triterpenoids, the main constituents being - and &beta;-amyrins. Methanolic extracts from Itapecerica and Paula C&acirc;ndido exhibited pronounced scavenging activity towards DPPH, indistinguishable from BHT activity. However, extracts from Virgin&oacute;polis sample exhibited no antioxidant activity. Total phenolic substances, GC/MS analyses and antioxidant activity of samples from Itapecerica collected monthly over a period of 1 year revealed considerable variation. No correlation was observed between antioxidant activity and either total phenolic contents or contents of artepillin C and other phenolic substances, as assayed by CG/MS analysis.</p>
]]></description>
<dc:creator><![CDATA[Teixeira, E. W., Message, D., Negri, G., Salatino, A., Stringheta, P. C.]]></dc:creator>
<dc:date>2008-01-31</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem177</dc:identifier>
<dc:title><![CDATA[Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-31</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen005v1?rss=1">
<title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen005v1?rss=1</link>
<description><![CDATA[
<p><I>Ki</I> (in Japanese) or <I>Qi</I> (in Chinese) is the key concept in Eastern medicine, Eastern philosophy, as well as in martial arts. We explain the philosophical and psychological background of <I>Ki</I>. We emphasize that the unique aspects of Eastern philosophy are &lsquo;non-linearity&rsquo; and &lsquo;holistic&rsquo; approach. We then present physics aspect of <I>Ki</I>. Our experiments demonstrated that a &lsquo;<I>Ki</I>-beam&rsquo; carries &lsquo;entropy&rsquo; (or information), which is different from &lsquo;energy&rsquo;. We introduce our experience of having taught <I>Ki</I> to 37 beginners in the United States through the Nishino Breathing Method. If beginners had martial arts training or a strong background in music or dance, about half of them could sense <I>Ki</I> within 10 weeks (1 h class per week) of practice.</p>
]]></description>
<dc:creator><![CDATA[Ohnishi, S. T., Ohnishi, T.]]></dc:creator>
<dc:date>2008-01-28</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen005</dc:identifier>
<dc:title><![CDATA[Philosophy, Psychology, Physics and Practice of Ki]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-28</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1">
<title><![CDATA[Antimicrobial, Antioxidant and Cytotoxic Activities and Phytochemical Screening of Some Yemeni Medicinal Plants]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen004v1?rss=1</link>
<description><![CDATA[
<p>The traditional medicine still plays an important role in the primary health care in Yemen. The current study represents the investigation of 16 selected plants, which were collected from different localities of Yemen. The plants were dried and extracted with two different solvents (methanol and hot water) to yield 34 crude extracts. The obtained extracts were tested for their antimicrobial activity against three Gram-positive bacteria, two Gram-negative bacteria, one yeast species and three multiresistant <I>Staphylococcus</I> strains using agar diffusion method, for their antioxidant activity using scavenging activity of DPPH radical method and for their cytotoxic activity using the neutral red uptake assay. In addition, a phytochemical screening of the methanolic extracts was done. Antibacterial activity was shown only against Gram-positive bacteria, among them multiresistant bacteria. The highest antimicrobial activity was exhibited by the methanolic extracts of <I>Acalypha fruticosa</I>, <I>Centaurea pseudosinaica</I>, <I>Dodonaea viscosa</I>, <I>Jatropha variegata</I>, <I>Lippia citriodora</I>, <I>Plectranthus hadiensis</I>, <I>Tragia pungens</I> and <I>Verbascum bottae.</I> Six methanolic extracts especially those of <I>A. fruticosa</I>, <I>Actiniopteris semiflabellata</I>, <I>D. viscosa</I>, <I>P. hadiensis</I>, <I>T. pungens</I> and <I>V. bottae</I> showed high free radical scavenging activity. Moreover, remarkable cytotoxic activity against FL-cells was found for the methanolic extracts of <I>A. fruticosa</I>, <I>Iris albicans</I>, <I>L. citriodora</I> and <I>T. pungens</I>. The phytochemical screening demonstrated the presence of different types of compounds like flavonoids, terpenoids and others, which could be responsible for the obtained activities.</p>
]]></description>
<dc:creator><![CDATA[Mothana, R. A. A., Abdo, S. A. A., Hasson, S., Althawab, F. M. N., Alaghbari, S. A. Z., Lindequist, U.]]></dc:creator>
<dc:date>2008-01-28</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen004</dc:identifier>
<dc:title><![CDATA[Antimicrobial, Antioxidant and Cytotoxic Activities and Phytochemical Screening of Some Yemeni Medicinal Plants]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-28</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem182v2?rss=1">
<title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem182v2?rss=1</link>
<description><![CDATA[
<p>We investigated the effects of group music intervention on aggression and self-esteem in children with highly aggressive behavior. Forty-eight children were allocated to either a music intervention group or an untreated control group. The music intervention group received 50 min of music intervention twice weekly for 15 consecutive weeks. The outcome measures were Child Behavior Checklist Aggression Problems Scale (Parents), Child Aggression Assessment Inventory (Teachers) and Rosenberg Self-esteem Scale. After 15 weeks, the music intervention group showed significant reduction of aggression and improvement of self-esteem compared with the control group. All outcome measures were significantly lower in the music intervention group than prior to treatment, while there was no change in the control group. These findings suggest that music can reduce aggressive behavior and improve self-esteem in children with highly aggressive behavior. Music intervention is an easily accessible therapy for children and as such may be an effective intervention for aggressive behavior. Further more, objective and replicable measures are required from a randomized controlled trial with a larger sample size and active comparable control.</p>
]]></description>
<dc:creator><![CDATA[Choi, A.-N., Lee, M. S., Lee, J.-S.]]></dc:creator>
<dc:date>2008-01-28</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem182</dc:identifier>
<dc:title><![CDATA[Group Music Intervention Reduces Aggression and Improves Self-esteem in Children with Highly Aggressive Behavior: A Pilot Controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-28</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nen002v1?rss=1">
<title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nen002v1?rss=1</link>
<description><![CDATA[
<p>Acupuncture is an ancient Chinese therapy with its mode of action unclear and efficacy inconclusive. A lack of attention given to the role of psychosocial context presented in clinical provision of acupuncture may mainly account for the current dilemma in acupuncture research. This psychosocial context induces various cognitive and affective processes in the patient while receiving this treatment. On the basis of the analysis of these psychological factors involved in clinical provision of acupuncture and in light of prior studies on the placebo effect, the author hypothesizes that acupuncture works through potentiation and modulation of a highly organized and somatotopic network of endogenous opioids that links expectation, attention and body schema. This hypothesis, which focuses on the contextual factors involved in clinical provision of acupuncture, has immediate clinical and experimental implications and will take the acupuncture debate much further forward.</p>
]]></description>
<dc:creator><![CDATA[Liu, T.]]></dc:creator>
<dc:date>2008-01-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nen002</dc:identifier>
<dc:title><![CDATA[Acupuncture: What Underlies Needle Administration?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1">
<title><![CDATA[A Comparison of Chinese and American Indian (Chumash) Medicine]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem188v1?rss=1</link>
<description><![CDATA[
<p>Chinese and Chumash traditional medical approaches are similar in terms of disease causation, use of acupuncture or healing touch, plants, spiritual and philosophical approaches. This article provides a brief comparison and discussion of Chinese and Chumash traditional medical practices. A table of 66 plants is presented along with Chinese and Chumash uses of each plant. These uses are compared and contrasted.</p>
]]></description>
<dc:creator><![CDATA[Adams, J. D., Garcia, C., Lien, E. J.]]></dc:creator>
<dc:date>2008-01-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem188</dc:identifier>
<dc:title><![CDATA[A Comparison of Chinese and American Indian (Chumash) Medicine]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1">
<title><![CDATA[Acupuncture Effects on Cardiac Functions Measured by Cardiac Magnetic Resonance Imaging in a Feline Model]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem187v1?rss=1</link>
<description><![CDATA[
<p>The usefulness of acupuncture (AP) as a complementary and/or alternative therapy in animals is well established but more research is needed on its clinical efficacy relative to conventional therapy, and on the underlying mechanisms of the effects of AP. Cardiac magnetic resonance imaging (CMRI), an important tool in monitoring cardiovascular diseases, provides a reliable method to monitor the effects of AP on the cardiovascular system. This controlled experiment monitored the effect electro-acupuncture (EA) at bilateral acupoint Neiguan (PC6) on recovery time after ketamine/xylazine cocktail anesthesia in healthy cats. The CMRI data established the basic feline cardiac function index (CFI), including cardiac output and major vessel velocity. To evaluate the effect of EA on the functions of the autonomic nervous and cardiovascular systems, heart rate, respiration rate, electrocardiogram and pulse rate were also measured. Ketamine/xylazine cocktail anesthesia caused a transient hypertension in the cats; EA inhibited this anesthetic-induced hypertension and shortened the post-anesthesia recovery time. Our data support existing knowledge on the cardiovascular benefits of EA at PC6, and also provide strong evidence for the combination of anesthesia and EA to shorten post-anesthesia recovery time and counter the negative effects of anesthetics on cardiac physiology.</p>
]]></description>
<dc:creator><![CDATA[Lin, J.-H., Shih, C.-H., Kaphle, K., Wu, L.-S., Tseng, W.-Y., Chiu, J.-H., Lee, T.-c., Wu, Y.-L.]]></dc:creator>
<dc:date>2008-01-23</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem187</dc:identifier>
<dc:title><![CDATA[Acupuncture Effects on Cardiac Functions Measured by Cardiac Magnetic Resonance Imaging in a Feline Model]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-23</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1">
<title><![CDATA[Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem186v1?rss=1</link>
<description><![CDATA[
<p>The purpose of this project was to conduct a systematic review to identify instruments designed to evaluate the quality of randomized controlled trials (RCTs) of natural health products (NHPs). Instruments were examined for inclusion of items assessing methods, identity and content of the NHP, generalizability of results and instructions for use. Online databases, websites, textbooks and reference lists were searched to identify instruments. Relevance assessment and data extraction of articles were completed by two investigators and disagreements were settled by the third investigator. Data were analyzed using descriptive statistics. Of the 4442 citations identified, 29 were potentially relevant with 16 meeting the criteria for inclusion. None of the instruments stated they were validated; content in the four areas of interest varied considerably. The most common items included randomization sequence generation (100%), blinding (100%), allocation concealment (75%) and participant flow (75%). Only nine of the NHP instruments included at least one item to appraise the specific content of the NHP. The CONSORT Statement for Herbal Interventions most closely addressed the four areas of interest; however, this instrument was specific for herbs. There is a need for the development of a validated instrument for assessment of the quality of RCTs that would be useful for herbs as well as other NHPs.</p>
]]></description>
<dc:creator><![CDATA[Whelan, A. M., Jurgens, T. M., Lord, L.]]></dc:creator>
<dc:date>2008-01-18</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem186</dc:identifier>
<dc:title><![CDATA[Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-18</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1">
<title><![CDATA[Complementary and Alternative Medicine Familiarization: What's happening in Medical Schools in Wales?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem185v1?rss=1</link>
<description><![CDATA[
<p>Despite recommendations that complementary and alternative medicine (CAM) familiarization should be offered to UK medical students, in Wales little such teaching was offered. We decided to assess medical students&rsquo; knowledge of CAMs, perceived training needs in CAMs, their view of its role in the National Health Service (NHS) and current teaching given. Analysis of data from a questionnaire given to medical students and direct questioning of senior academic medical school staff in Cardiff and Swansea Medical Schools was carried out. The participants comprised 78 first year medical students in the undergraduate entry program in Cardiff and 58 first year medical students from the graduate entry program in Swansea. Senior academic medical school staff at Cardiff and Swansea Medical Schools were asked about current CAM teaching. Results revealed that 32% of undergraduate entry students (UGES) had previous knowledge of CAMs compared with 51% of graduate entry students (GES). Of the UGES, 62% believed they should be taught about CAM's compared with 94% of GES. Of UGES 31% felt that CAMs have a role in the NHS compared with 50% of GES. None of the students had received teaching about CAMs and little formal CAM teaching is currently included in the curricula at each site. The majority of medical students in Wales would like to receive CAM teaching and significant numbers support a role for CAMs in the NHS. Little formal teaching is currently provided.</p>
]]></description>
<dc:creator><![CDATA[Taylor, N., Blackwell, A.]]></dc:creator>
<dc:date>2008-01-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem185</dc:identifier>
<dc:title><![CDATA[Complementary and Alternative Medicine Familiarization: What's happening in Medical Schools in Wales?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1">
<title><![CDATA[Anti-microbial Activity of Urine after Ingestion of Cranberry: A Pilot Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem183v1?rss=1</link>
<description><![CDATA[
<p>We explore the anti-microbial activity of urine specimens after the ingestion of a commercial cranberry preparation. Twenty subjects without urinary infection, off antibiotics and all supplements or vitamins were recruited. The study was conducted in two phases: in phase 1, subjects collected the first morning urine prior to ingesting 900 mg of cranberry and then at 2, 4 and 6 h. In phase 2, subjects collected urine on 2 consecutive days: on Day 1 no cranberry was ingested (control specimens), on Day 2, cranberry was ingested. The pH of all urine specimens were adjusted to the same pH as that of the first morning urine specimen. Aliquots of each specimen were independently inoculated with <I>Escherichia coli</I>, <I>Klebsiella pneumoniae</I> or <I>Candida albicans</I>. After incubation, colony forming units/ml (CFU ml<sup>&ndash;1</sup>) in the control specimen was compared with CFU ml<sup>&ndash;1</sup> in specimens collected 2, 4 and 6 h later. Specimens showing &ge;50% reduction in CFU ml<sup>&ndash;1</sup> were considered as having &lsquo;activity&rsquo; against the strains tested. In phase 1, 7/20 (35%) subjects had anti-microbial activity against <I>E</I>. <I>coli</I>, 13/20 (65%) against <I>K</I>. <I>pneumoniae</I> and 9/20 (45%) against <I>C</I>. <I>albicans</I> in specimens collected 2&ndash;6 h after ingestion of cranberry. In phase 2, 6/9 (67%) of the subjects had activity against <I>K</I>. <I>pneumoniae</I>. This pilot study demonstrates weak anti-microbial activity in urine specimens after ingestion of a single dose of commercial cranberry. Anti-microbial activity was noted only against <I>K</I>. <I>pneumoniae</I> 2&ndash;6 h after ingestion of the cranberry preparation.</p>
]]></description>
<dc:creator><![CDATA[Lee, Y. L., Najm, W. I., Owens, J., Thrupp, L., Baron, S., Shanbrom, E., Cesario, T.]]></dc:creator>
<dc:date>2008-01-16</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem183</dc:identifier>
<dc:title><![CDATA[Anti-microbial Activity of Urine after Ingestion of Cranberry: A Pilot Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-16</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1">
<title><![CDATA[Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid 'Ashwagandha' in Prostate Cancer Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem184v1?rss=1</link>
<description><![CDATA[
<p>Phytochemicals are dietary phytoestrogens that may play a role in prostate cancer prevention. Forty percent of Americans use complementary and alternative medicines (CAM) for disease prevention and therapy. Ashwagandha (<I>Withania somnifera</I>) contains flavonoids and active ingredients like alkaloids and steroidal lactones which are called &lsquo;Withanolides&rsquo;. We hypothesize that the immunomodulatory and anti-inflammatory properties of Ashwagandha might contribute to its overall effectiveness as an anti-carcinogenic agent. The goal of our study was gain insight into the general biological and molecular functions and immunomodulatory processes that are altered as a result of Ashwagandha treatment in prostate cancer cells, and to identify the key signaling mechanisms that are involved in the regulation of these physiological effects using genomic microarray analysis in conjunction with quantitative real-time PCR and western blot analysis. Ashwagandha treatment significantly downregulated the gene and protein expression of proinflammatory cytokines IL-6, IL-1&beta;, chemokine IL-8, Hsp70 and STAT-2, while a reciprocal upregulation was observed in gene and protein expression of p38 MAPK, PI3K, caspase 6, Cyclin D and c-myc. Furthermore, Ashwagandha treatment significantly modulated the JAK-STAT pathway which regulates both the apoptosis process as well as the MAP kinase signaling. These studies outline several functionally important classes of genes, which are associated with immune response, signal transduction, cell signaling, transcriptional regulation, apoptosis and cell cycle regulation and provide insight into the molecular signaling mechanisms that are modulated by Ashwagandha, thereby highlighting the use of this bioflavanoid as effective chemopreventive agent relevant to prostate cancer progression.</p>
]]></description>
<dc:creator><![CDATA[Aalinkeel, R., Hu, Z., Nair, B. B., Sykes, D. E., Reynolds, J. L., Mahajan, S. D., Schwartz, S. A.]]></dc:creator>
<dc:date>2008-01-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem184</dc:identifier>
<dc:title><![CDATA[Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid 'Ashwagandha' in Prostate Cancer Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-10</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1">
<title><![CDATA[Pediatric Acupuncture: A Review of Clinical Research]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem181v1?rss=1</link>
<description><![CDATA[
<p>Practiced in China for more than 2000 years, acupuncture has recently gained increased attention in the United States as an alternative treatment approach for a variety of medical conditions. Despite its growing prevalence and anecdotal reports of success among pediatric populations, few empirically based studies have assessed the efficacy of acupuncture for children and adolescents. This article presents a review of the current literature, including a systematic appraisal of the methodological value of each study and a discussion of potential benefits and adverse effects of acupuncture. While acupuncture holds great promise as a treatment modality for diverse pediatric conditions, a significant amount of additional research is necessary to establish an empirical basis for the incorporation of acupuncture into standard care.</p>
]]></description>
<dc:creator><![CDATA[Gold, J. I., Nicolaou, C. D., Belmont, K. A., Katz, A. R., Benaron, D. M., Yu, W.]]></dc:creator>
<dc:date>2008-01-10</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem181</dc:identifier>
<dc:title><![CDATA[Pediatric Acupuncture: A Review of Clinical Research]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-10</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem174v1?rss=1">
<title><![CDATA[Non Conventional Medicine in Italy. History, Problems, Prospects for Integration]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem174v1?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Nuzzi, R.]]></dc:creator>
<dc:date>2008-01-08</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem174</dc:identifier>
<dc:title><![CDATA[Non Conventional Medicine in Italy. History, Problems, Prospects for Integration]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-08</prism:publicationDate>
<prism:section>Book Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1">
<title><![CDATA[The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem180v1?rss=1</link>
<description><![CDATA[
<p><I>Boehmeria nivea</I> extract (BNE) is widely used in southern Taiwan as a folk medicine for hepato-protection and hepatitis treatment. In previous studies, we demonstrated that BNE could reduce the supernatant hepatitis B virus (HBV) DNA in HBV-producing HepG2 2.2.15 cells. In the present study, we established an animal model of HBV viremia and used it to validate the efficacy of BNE <I>in vivo</I>. In this animal model, serum HBV DNA and HBsAg were elevated in accordance with tumor growth. To evaluate the anti-HBV activity of BNE, HBV-viremia mice were built up after one subcutaneous inoculation of HepG2 2.2.15 tumor cells in severe combined immunodeficiency mice over 13 days. The levels of serum HBV DNA were elevated around 10<sup>5</sup>&ndash;10<sup>6</sup> copies per milliliter. Both oral and intraperitoneal administration of BNE were effective at inhibiting the production of HBsAg and HBV DNA, whereas tumor growth was not affected by all test articles. Intraperitoneal administration of BNE appeared to have greater potential to inhibit serum HBV DNA levels compared with oral administration under the same dosage. Notably, reduced natural killer cell activity was also observed after high dosage of BNE administration, and this correlated with reduced serum HBV DNA. In conclusion, BNE exhibited potential anti-HBV activity in an animal model of HBV viremia.</p>
]]></description>
<dc:creator><![CDATA[Chang, J.-M., Huang, K.-L., Yuan, T. T.-T., Lai, Y.-K., Hung, L.-M.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem180</dc:identifier>
<dc:title><![CDATA[The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem179v1?rss=1">
<title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem179v1?rss=1</link>
<description><![CDATA[
<p>This study evaluated whether improvements in nicotine withdrawal symptoms (NWS), depression and anxiety are greater for body acupuncture than for sham acupuncture. Smoking volunteers from the public were randomized to receive six sessions of either real or sham acupuncture for 2 weeks. The primary outcome measure was NWS measured by the Minnesota Nicotine Withdrawal Score, and the secondary measures were scores on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI). Eighty volunteers were randomized into real acupuncture (<I>n</I> = 38) and sham acupuncture (<I>n</I> = 42) groups, of which 46 subjects (22 and 24 in the real and sham acupuncture groups, respectively) completed the treatment and the 2-week follow-up. An intention-to-treat analysis revealed that the NWS did not differ significantly between the real and sham acupuncture groups immediately after the treatment (12.2 &plusmn; 9.7 and 12.8 &plusmn; 7.7, respectively; mean &plusmn; SD) and at the 2-week follow-up (11.7 &plusmn; 10.2 and 12.6 &plusmn; 7.8). Both groups also showed similar improvements in BDI and BAI scores. These results indicate that the real acupuncture treatment tested in this trial was no more effective than sham acupuncture at reducing NWS, depression and anxiety for smoking cessation.</p>
]]></description>
<dc:creator><![CDATA[Hyun, M.-K., Lee, M. S., Kang, K., Choi, S.-M.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem179</dc:identifier>
<dc:title><![CDATA[Body Acupuncture for Nicotine Withdrawal Symptoms: A Randomized Placebo-controlled Trial]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1">
<title><![CDATA[Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem176v1?rss=1</link>
<description><![CDATA[
<p>Reactive oxygen species (ROS) have been implicated in the pathogenesis of a wide range of acute and long-term neurodegenerative diseases. This study was undertaken to examine the efficacy of <I>Pogostemon cablin</I>, a well-known herb in Korean traditional medicine, on ROS-induced brain cell injury. <I>Pogostemon cablin</I> effectively protected human neuroglioma cell line A172 against both the necrotic and apoptotic cell death induced by hydrogen peroxide (H<SUB>2</SUB>O<SUB>2</SUB>). The effect of <I>Pogostemon cablin</I> was dose dependent at concentrations ranging from 0.2 to 5 mg ml<sup>&ndash;1</sup>. <I>Pogostemon cablin</I> significantly prevented depletion of cellular ATP and activation of poly ADP-ribose polymerase induced by H<SUB>2</SUB>O<SUB>2</SUB>. The preservation of functional integrity of mitochondria upon the treatment of <I>Pogostemon cablin</I> was also confirmed by 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2-H-tetrazolium bromide assay. Furthermore, <I>Pogostemon cablin</I> significantly prevented H<SUB>2</SUB>O<SUB>2</SUB>-induced release of cytochrome c into cytosol. Determination of intracellular ROS showed that <I>Pogostemon cablin</I> might exert its role as a powerful scavenger of intracellular ROS. The present study suggests the beneficial effect of <I>Pogostemon cablin</I> on ROS-induced neuroglial cell injury. The action of <I>Pogostemon cablin</I> as a ROS-scavenger might underlie the mechanism.</p>
]]></description>
<dc:creator><![CDATA[Kim, H. W., Cho, S. J., Kim, B.-Y., Cho, S. I., Kim, Y. K.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem176</dc:identifier>
<dc:title><![CDATA[Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem175v1?rss=1">
<title><![CDATA[Medical Honey for Wound Care Still the 'Latest Resort'?]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem175v1?rss=1</link>
<description><![CDATA[
<p>While the ancient Egyptians and Greeks used honey for wound care, and a broad spectrum of wounds are treated all over the world with natural unprocessed honeys from different sources, Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> has been one of the first medically certified honeys licensed as a medical product for professional wound care in Europe and Australia. Our experience with medical honey in wound care refers only to this product. In this review, we put our clinical experience into a broader perspective to comment on the use of medical honey in wound care. More prospective randomized studies on a wider range of types of wounds are needed to confirm the safety and efficacy of medical honey in wound care. Nonetheless, the current evidence confirming the antibacterial properties and additional beneficial effects of medical honey on wound healing should encourage other wound care professionals to use CE-certified honey dressings with standardized antibacterial activity, such as Medihoney<SUP><SMALL><SMALL>TM</SMALL></SMALL></SUP> products, as an alternative treatment approach in wounds of different natures.</p>
]]></description>
<dc:creator><![CDATA[Simon, A., Traynor, K., Santos, K., Blaser, G., Bode, U., Molan, P.]]></dc:creator>
<dc:date>2008-01-07</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem175</dc:identifier>
<dc:title><![CDATA[Medical Honey for Wound Care Still the 'Latest Resort'?]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-07</prism:publicationDate>
<prism:section>Commentary</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1">
<title><![CDATA[Ginseng on Hyperglycemia: Effects and Mechanisms]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem178v1?rss=1</link>
<description><![CDATA[
<p>It has been reported that American ginseng attenuates hyperglycemia and may present itself as a supplement to diabetes therapy. However, the lack of standardization in the usage of ginseng root leads to inconclusive results when applied to diabetes treatment. The mechanisms of American ginseng root in the treatment of diabetes remains a mystery. This greatly limits the effective utilization of American ginseng in facilitating diabetic therapy. Initiating studies have shown that American ginseng increases insulin production and reduces cell death in pancreatic &beta;-cells. Also, studies have revealed American ginseng's ability to decrease blood glucose in type II diabetes patients as well as in streptozotocin-induced diabetic animals (STZ-diabetic mice). These data suggest that effects of ginseng in improving hyperglycemia may alter mitochondrial function as well as apoptosis cascades to ensure cell viability in pancreatic islet cells. This review briefly summarizes current knowledge of ginseng components and clinical studies related to diabetes. Further research will be needed to explore and identify the component(s) of ginseng, which may be responsible for the beneficial effects observed in animal studies which could then be extrapolated to human islets.</p>
]]></description>
<dc:creator><![CDATA[Luo, J. Z., Luo, L.]]></dc:creator>
<dc:date>2008-01-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem178</dc:identifier>
<dc:title><![CDATA[Ginseng on Hyperglycemia: Effects and Mechanisms]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-03</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1">
<title><![CDATA[Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem140v2?rss=1</link>
<description><![CDATA[
<p>We previously reported that catechins of green tea have different antiproliferative effects on cell lines derived from gender-dependent cancers; epicatechin 3-gallate (ECG) had the strongest inhibitory effect. In the present study, we examined the effects of epigallocatechin (EGC), epicatechin-gallate (ECG) and EGC 3-gallate (EGCG) on the viability, density, doubling time and cycle number of cell lines derived from melanoma metastasized to lymph nodes (MB-1133 and SE-0154) or distant organs (CH-0356, JK-0346, SA-1171, GE-0208, NS-1176 and LF-0023). These catechins have been documented to have no growth suppressive or apoptotic effects on normal melanocytes (Nihal et al., <I>Int J Cancer</I> 2005;114:513&ndash;21). EGCG (50 &micro;M) showed greater inhibitory potency than EGC (50 &micro;M) in SE-0154, NS-1176, GE-0208 and LF-0023 cell lines but the two catechins produced similar inhibitory effects in CH-0356, JK-0346 and SA-1171 cell lines. The IC<SUB>50</SUB> (50% inhibitory concentration) was lower for EGC than EGCG in MB-1133 and CH-0356 cells, higher for EGC than EGCG in GE-0208 cells and comparable (11&ndash;12 &micro;M) for both the catechins in LF-0023 cells. When compared with EGC, the cytotoxic effect (% dead cell counts) and the suppression of the growth (change in cell number) of all melanoma cell lines tested were pronounced with EGCG. This investigation validates the hypothesis that anticancer action of the various catechins may vary with the type of malignancy and provides a model for tumor cell heterogeneity based on susceptibility and resistance of tumor cells to different green tea catechins. Therefore, this information is critical for undertaking chemopreventive or chemotherapeutic trials against melanoma and gender-based cancers.</p>
]]></description>
<dc:creator><![CDATA[Ravindranath, M. H., Ramasamy, V., Moon, S., Ruiz, C., Muthugounder, S.]]></dc:creator>
<dc:date>2008-01-03</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem140</dc:identifier>
<dc:title><![CDATA[Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG)]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2008-01-03</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1">
<title><![CDATA[Comfrey (Symphytum Officinale. L.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem172v1?rss=1</link>
<description><![CDATA[
<p>Comfrey or <I>Symphytum officinale</I> (L.) (Boraginaceae) is a very popular plant used for therapeutic purposes. Since the 1980s, its effects have been studied in long-term carcinogenesis studies, in which Comfrey extract is administered at high doses during several months and the neoplastic hepatic lesions are evaluated. However, the literature on this topic is very poor considering the studies performed under short-term carcinogenesis protocols, such as the &lsquo;resistant hepatocyte model&rsquo; (RHM). In these studies, it is possible to observe easily the phenomena related to the early phases of tumor development, since pre-neoplastic lesions (PNLs) rise in about 1&ndash;2 months of chemical induction. Herein, the effects of chronic oral treatment of rats with 10% Comfrey ethanolic extract were evaluated in a RHM. Wistar rats were sequentially treated with <I>N</I>-nitrosodiethylamine (ip) and 2-acetilaminofluorene (po), and submitted to hepatectomy to induce carcinogenesis promotion. Macroscopic/microscopic quantitative analysis of PNL was performed. Non-parametric statistical tests (Mann&ndash;Whitney and <sup>2</sup>) were used, and the level of significance was set at <I>P</I> &le; 0.05. Comfrey treatment reduced the number of pre-neoplastic macroscopic lesions up to 1 mm (<I>P</I> &le; 0.05), the percentage of oval cells (<I>P</I> = 0.0001) and mitotic figures (<I>P</I> = 0.007), as well as the number of Proliferating Cell Nuclear Antigen (PCNA) positive cells (<I>P</I> = 0.0001) and acidophilic pre-neoplastic nodules (<I>P</I> = 0.05). On the other hand, the percentage of cells presenting megalocytosis (<I>P</I> = 0.0001) and vacuolar degeneration (<I>P</I> = 0.0001) was increased. Scores of fibrosis, glycogen stores and the number of nucleolus organizing regions were not altered. The study indicated that oral treatment of rats with 10% Comfrey alcoholic extract reduced cell proliferation in this model.</p>
]]></description>
<dc:creator><![CDATA[Gomes, M. F. P. L., de Oliveira Massoco, C., Xavier, J. G., Bonamin, L. V.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem172</dc:identifier>
<dc:title><![CDATA[Comfrey (Symphytum Officinale. L.) and Experimental Hepatic Carcinogenesis: A Short-term Carcinogenesis Model Study]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1">
<title><![CDATA[The MIQ-RS: A Suitable Option for Examining Movement Imagery Ability]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem170v1?rss=1</link>
<description><![CDATA[
<p>Within rehabilitation settings, mental imagery helps to promote long-term recovery and facilitates compliance to rehabilitation exercises. Individuals who are able to effectively engage in imagery practice are likely to gain the most benefit from imagery training. Thus, a suitable imagery ability measurement tool for individuals with movement limitations is needed. The purpose of the present study was to evaluate the Movement Imagery Questionnaire&mdash;Revised second version (MIQ-RS), and compare the results of this new version with Hall and Martin's (1997) MIQ-R. Three-hundred and twenty participants from a variety of sports and performance levels agreed to take part. Results showed the internal consistency and test&ndash;retest reliability of the MIQ-RS were satisfactory, the two-factor structure of the MIQ-RS was supported by confirmatory factor analysis, and Pearson correlations indicated a strong relationship between the MIQ-R and MIQ-RS. It appears the MIQ-RS is a suitable option for examining movement imagery ability primarily aimed at the upper extremity.</p>
]]></description>
<dc:creator><![CDATA[Gregg, M., Hall, C., Butler, A.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem170</dc:identifier>
<dc:title><![CDATA[The MIQ-RS: A Suitable Option for Examining Movement Imagery Ability]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1">
<title><![CDATA[Catalytic Therapy of Cancer with Ascorbate and Extracts of Medicinal Herbs]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem159v1?rss=1</link>
<description><![CDATA[
<p>Catalytic therapy (CT) is a cancer treatment modality based on the generation of reactive oxygen species (ROS) using a combination of substrate molecules and a catalyst. The most frequently used substrate/catalyst pair is ascorbate/Co phthalocyanine (PcCo). In the present work, herb extracts containing pigments have been studied as a catalyst in place of PcCo. Extracts from herbs are expected to have efficiency comparable with that of phthalocyanines but as natural products, to exhibit fewer side effects. The present studies demonstrate that a combined use of ascorbate and herbal extracts results in ROS production and a significant decrease in the number of cancer cells after a single <I>in vitro</I> treatment. Treatment with ascorbate in conjunction with extracts prepared from several medicinal herbs stimulated apoptosis and disrupted the cell cycle. The number of cells accumulating in the sub-G0/G1 stage of the cell cycle was increased 2- to 7-fold, and cells in G<SUB>2</SUB>/M increased 1.5- to 20-fold, indicating that the treatment protocol was highly effective in suppressing DNA synthesis and potentially reflecting DNA damage in the tumor cells. In addition, 20&ndash;40% of the cells underwent apoptosis within 24 h of completing treatment. Our results suggest that herbal extracts can function as CT catalysts in the treatment of cancer.</p>
]]></description>
<dc:creator><![CDATA[Rozanova, N., Zhang, J. Z., Heck, D. E.]]></dc:creator>
<dc:date>2007-12-26</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem159</dc:identifier>
<dc:title><![CDATA[Catalytic Therapy of Cancer with Ascorbate and Extracts of Medicinal Herbs]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-26</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1">
<title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem171v1?rss=1</link>
<description><![CDATA[
<p>The present investigation was undertaken to assess the role of <I>Mucuna pruriens</I> in infertile men who were under psychological stress. Study included 60 subjects who were undergoing infertility screening and were found to be suffering from psychological stress, assessed on the basis of a questionnaire and elevated serum cortisol levels. Age-matched 60 healthy men having normal semen parameters and who had previously initiated at least one pregnancy were included as controls. Infertile subjects were administered with <I>M. pruriens</I> seed powder (5 g day<sup>&ndash;1</sup>) orally. For carrying out morphological and biochemical analysis, semen samples were collected twice, first before starting treatment and second after 3 months of treatment. The results demonstrated decreased sperm count and motility in subjects who were under psychological stress. Moreover, serum cortisol and seminal plasma lipid peroxide levels were also found elevated along with decreased seminal plasma glutathione (GSH) and ascorbic acid contents and reduced superoxide dismutase (SOD) and catalase activity. Treatment with <I>M. pruriens</I> significantly ameliorated psychological stress and seminal plasma lipid peroxide levels along with improved sperm count and motility. Treatment also restored the levels of SOD, catalase, GSH and ascorbic acid in seminal plasma of infertile men. On the basis of results of the present study, it may be concluded that <I>M. pruriens</I> not only reactivates the anti-oxidant defense system of infertile men but it also helps in the management of stress and improves semen quality.</p>
]]></description>
<dc:creator><![CDATA[Shukla, K. K., Mahdi, A. A., Ahmad, M. K., Jaiswar, S. P., Shankwar, S. N., Tiwari, S. C.]]></dc:creator>
<dc:date>2007-12-18</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem171</dc:identifier>
<dc:title><![CDATA[Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-18</prism:publicationDate>
<prism:section>Original Article</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem139v1?rss=1">
<title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of  -Thalassemia and Sickle-Cell Anemia]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem139v1?rss=1</link>
<description><![CDATA[
<p>The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of &beta;-thalassemia using molecules able to stimulate production of fetal hemoglobin (HbF) in adults. Concerning the employment of HbF inducers as potential drugs for pharmacological treatment of &beta;-thalassemia, the following conclusions can be reached: (i) this therapeutic approach is reasonable, on the basis of the clinical parameters exhibited by hereditary persistence of fetal hemoglobin patients, (ii) clinical trials (even if still limited) employing HbF inducers were effective in ameliorating the symptoms of &beta;-thalassemia patients, (iii) good correlation of <I>in vivo</I> and <I>in vitro</I> results of HbF synthesis and -globin mRNA accumulation indicates that <I>in vitro</I> testing might be predictive of <I>in vivo</I> responses and (iv) combined use of different inducers might be useful to maximize HbF, both <I>in vitro</I> and <I>in vivo</I>. In this review, we present three examples of HbF inducers from the natural world: (i) angelicin and linear psoralens, contained in plant extracts from <I>Angelica arcangelica</I> and <I>Aegle marmelos</I>, (ii) resveratrol, a polyphenol found in grapes and several plant extracts and (iii) rapamycin, isolated from <I>Streptomyces hygroscopicus</I>.</p>
]]></description>
<dc:creator><![CDATA[Bianchi, N., Zuccato, C., Lampronti, I., Borgatti, M., Gambari, R.]]></dc:creator>
<dc:date>2007-12-11</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem139</dc:identifier>
<dc:title><![CDATA[Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of  -Thalassemia and Sickle-Cell Anemia]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-11</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1">
<title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem167v1?rss=1</link>
<description><![CDATA[
<p>Health care spending in North America is consuming an ever-increasing share of Gross Domestic Product (GDP). A large proportion of alternative health care is consumed in the form of natural health products (NHPs). The question of whether or not NHPs may provide a cost-effective choice in the treatment of disease is important for patients, physicians and policy makers. The objective of this study was to conduct a systematic review of the literature in order to find, appraise and summarize high-quality studies that explore the cost effectiveness of NHPs as compared to conventional medicine. The following databases were searched independently in duplicate from inception to January 1, 2006: EMBASE, MEDLINE, CINAHL, BioethicsLine, Wilson General Science abstracts, EconLit, Cochrane Library, ABI/Inform and SciSearch. To be included in the review, trials had to be randomized, assessed for some measure of cost effectiveness and include the use of NHPs as defined by the Natural Health Products Directorate. Studies dealing with diseases due to malnutrition were excluded from appraisal. The pooled searches unveiled nine articles that fit the inclusion/exclusion criteria. The conditions assessed by the studies included three on postoperative complications, two on cardiovascular disease, two on gastrointestinal disorders, one on critically ill patients and one on urinary tract infections. Heterogeneity between the studies was too great to allow for meta-analysis of the results. The use of NHPs shows evidence of cost effectiveness in relation to postoperative surgery but not with respect to the other conditions assessed. In conclusion, NHPs may be of use in preventing complications associated with surgery. The cost effectiveness of some NHPs is encouraging in certain areas but needs confirmation from further research.</p>
]]></description>
<dc:creator><![CDATA[Kennedy, D. A., Hart, J., Seely, D.]]></dc:creator>
<dc:date>2007-12-05</dc:date>
<dc:identifier>info:doi/10.1093/ecam/nem167</dc:identifier>
<dc:title><![CDATA[Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:publicationDate>2007-12-05</prism:publicationDate>
<prism:section>Review</prism:section>
</item>

<item rdf:about="http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1">
<title><![CDATA[Guarana's Journey from Regional Tonic to Aphrodisiac and Global Energy Drink]]></title>
<link>http://ecam.oxfordjournals.org/cgi/content/short/nem162v1?rss=1</link>
<description><![CDATA[
<p>Guaran&aacute; (<I>Paullinia cupana</I> H.B.K., Sapindaceae) is a rainforest vine that was domesticated in the Amazon for its caffeine-rich fruits. Guaran&aacute; has long been used as a tonic and to treat various disorders in Brazil and abroad and became a national soda in Brazil about a century ago. In the last two decades or so, guaran&aacute; has emerged as a key ingredient in various &lsquo;sports&rsquo; and energy drinks as well as concoctions that allegedly boost one's libido. For some time, guaran&aacute;'s high caffeine content was thought to be a detriment because of health concerns about excessive intake of caffeine-rich drinks. But it is precisely this quality, and the fact that it has a mysterious name and comes from an exotic land, that has propelled guaran&aacute; into a global beverage.</p>
]]></description>
<dc:creator><![CDATA[Smith, N., Atroch, A. L.]]></dc:creator>
<dc:date>2007-1